Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Conditions: Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Metastatic Cancer; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Precancerous Condition; Secondary Myelofibrosis; Unspecified Adult Solid Tumor, Protocol SpecificIntervention: Drug: PemetrexedSponsors: Northwestern University; National Cancer Institute (NCI)Active, not recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Cancer | Cancer & Oncology | Chronic Myeloproliferative Neoplasm | Leukemia | Lymphoma | Neoplastic Meningitis | Research